MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$18,519,784
Prepaid expenses
$1,770,844
Other receivables
$687,756
Other current assets
$680,753
Total current assets
$21,659,137
Other non-current
assets
$2,442,450
Property and equipment,
net
$1,448,990
Finance lease
right-of-use asset
$1,308,581
Operating lease
right-of-use assets
$969,256
Total assets
$27,828,414
Total liabilities and
stockholders' equity
$27,828,414
Total liabilities
$27,093,963
Total stockholders'
equity
$734,451
Accumulated deficit
-$191,688,793
Accumulated other
comprehensive loss
-$377,081
Total current
liabilities
$21,119,013
Liability related to the
sale of future...
$5,556,697
Lease liabilities
long-term, operating
$418,253
Additional paid-in capital
$192,798,213
Common stock, 0.0001
par value...
$1,456
Preferred stock, 0.01 par
value, 5,000,000...
$656
Deferred grant funding
$18,150,459
Accounts payable
$1,231,086
Current portion of lease
liabilities, operating
$598,556
Current portion of lease
liability, finance
$597,552
Accrued expenses
$529,325
Current portion of
liability related to the...
$12,035
Back
Back
Balance Sheet
Dare Bioscience, Inc. (DARE)
Dare Bioscience, Inc. (DARE)
source: myfinsight.com